Cite

HARVARD Citation

    Danova, M. et al. (2011). Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors. Expert review of anticancer therapy. 11 (8), pp. 1303-1313. [Online]. 
  
Back to record